If you are over the age of 18 years old who experience 2-8 migraines per month. The study drug is a CGRP receptor blocker administered through a nasal spray. Compensation is available up to $250 for those who qualify.
*Compensation for time and travel may be available to those who qualify.
This is a 15 week long research study for people who get 2-8 migraines a month. This is an oral medication that could potentially reduce migraine symptoms once a migraine begins.
Contact us to be added to our database and you’ll be first to know about our future studies that may be right for you.